πWhat a year! As we close 2025, we celebrate 10 webinars, 3 awareness campaigns, 14 steering meetings, and growing audiences across all our platforms.
Huge thanks to our committees, supporters & team who make it all possible.
Read more πhttps://t.co/dlvzTcbSCy
πHappy Holidays!
Leading AI in medical education! We shared our expertise at gCMEp & our new article highlights SES Studio β our AI platform transforming scientific writing. See how we turn complex research into clear contentπ https://t.co/ZSV6ZvT5ZN
#MedEd#AIinHealthcare#MedicalCommunications
Curated ASH 2025 top abstracts + real-time updates from congress sessions. Stay informed with expert insights, live feeds, and social coverage β follow our hubs!
Read more + find links to all our top abstracts here π https://t.co/lm52Yk5sSx
#ASH25#MedicalEducation#Hematology
Watch the GvHD Hub symposium on improving treatment of SR-GvHD, with Mohamad Mohty, Daniel Wolff, and Steven Pavletic.
π Read more: https://t.co/AHgQiYAL4q
π¬ Watch: https://t.co/AHgQiYAL4q
π€Interested in supporting webinars? Contact us! https://t.co/xiQv45GvDp
#GvHD#GvHDsm
Join top multiple myeloma experts on Dec 17, 17:30 GMT, for a 60-min virtual symposium on BCMA-directed therapies. Gain real-world insights, patient selection, and toxicity management strategies.
Register now π https://t.co/L3PRqsLKjg
#MultipleMyeloma#BCMATherapy
Join AML experts Gail Roboz, Jorge Sierra, and Jorge Cortes on Nov 19 to explore FLT3-ITD vs -TKD mutations in AML, treatment implications, and resistance management. Free webinar + live Q&A!
π https://t.co/nLrCeZ68KP
#AML#Hematology#MedicalEducation#HematologyEducation
On September 20, Know ALL marked World ALL Day! The interactive webpage reached 59β―countries with 20K+ page views π https://t.co/bTW0h2CYzZ
Read more about the achievements on our blog π https://t.co/sAbaQlZzzm
#WorldALLDay#AcuteLymphoblasticLeukemia#PatientEmpowerment
FREE Virtual Symposium | Oct 21, 17:00-18:30 BST
Guidance vs Practice: Improving SR-GvHD Treatment
Featuring Prof. Mohamad Mohty, Daniel Wolff & Steven Pavletic
Learn about novel therapies, latest data & QoL management
Register: https://t.co/atF3pPVVKG
#GvHD#MedEd#Hematology
Science moves fast β too fast to keep up alone. SES simplifies access to trusted, relevant knowledge for HCPs and patients. Include SES in your 2026 budget to support impactful IME.
Read more π https://t.co/xQnDjhXEFA
#MedicalEducation#IME#PatientEducation#Hematology
#BloodCancerAwarenessMonth Two free webinars!
Know ALL (Sep 22, 3:30β―PM BST): Immunotherapy and its impact on ALL treatment
Know GvHD (Sep 24, 5:00β―PM BST): Resources, updates, and community insights
Find out more and register π https://t.co/6cung7ubBh
#ALL#GvHD#BloodCancer
September 20 marks the 4th #WorldALLDay! @sci_ed_support joins the global community in raising awareness of ALL. The campaign focuses on improving ALL understanding and empowering patients by honoring their experiences.
Join the campaign: https://t.co/SfNmsoQEoa
#KnowALL
SES monthly newsletter dropping soon!
π¬ EULAR 2025 insights
π€ AI in CME practices
π Know ALL Ambassador stories
From rheumatology breakthroughs to patient voices - don't miss out!
Sign up β‘οΈ https://t.co/9KJN9r6lzW
#MedEd#CME#PatientVoice
Our Know ALL ambassador group united on July 1 β Jaymz and Jess (both ALL survivors) discussed managing immunotherapy side effects with Prof. Mark Litzow.
Visit Know ALL π https://t.co/rr8W4XpJX3
More SES events π https://t.co/vCiYqPLJ58
#ALLAwareness#PatientVoices
π SES recently joined industry experts to explore AI's game-changing impact on CME/CPD! Trevor Aukim and Mia Hill shared insights on using generative AI in medical education β from content creation to outcomes analysis. Read more π https://t.co/MO4aABNv4j
#MedEd#AI#CME
π Exciting insights from #EULAR2025!
In-depth coverage on lupus and psoriasis, ensuring healthcare professionals worldwide have access to the latest advancements.
Explore π
https://t.co/TGP49uDFh9
https://t.co/VAxlAiNzLA
#MedicalEducation#RheumTwitter#Lupus#psoriasis
We're proud to contribute to important @jecme research! Our study tackles the challenge of measuring #ContinuingEducation impact in diverse healthcare audiences. SES is already implementing these evidence-based solutions in our education programs π https://t.co/dI5iIIpwca
#MedEd
SES was proud to attend #EHA2025, delivering real-time expert insights and coverage of this leading hematology congress.
Explore all our EHA 2025 live coverage on the hubs visit our SES blog article π https://t.co/23HriydvYv
#MedicalEducation#Hematology